0321: PTP1B gene deletion or pharmacological inhibition improves glucose metabolism and limits cardiovascular dysfunction in experimental septic shock  by Delile, Eugénie et al.
© Elsevier Masson SAS. All rights reserved.
 
24 Archives of Cardiovascular Diseases Supplements (2014) 6, 23-25
O-GlcNAcylation, and various enzymes involved), and biological parameters
(urea, creatinine, pH, PCO2, PO2).
Cardiovascular function was strongly modified with a reduction in blood
pressure (–25%) in LPS injected rats, while no improvement was reported nei-
ther after GLCN nor NbutGT treatment. An increase in global O-GlcNAcyla-
tion was only obtained under GLCN and NbutGT treatment. GLCN led to an
increase in two enzymes involved in HBP regulation (GFAT and O-GlcNAse).
LPS injected rats presented a lactic acidosis associating an increase in lactate
(3.38±0.67 mmol/L vs 6.37±0.66) and drastic reduction in HCO3-. Urea and
creatinine were increased suggesting an acute renal failure. Treatment with
NbutGT but not GLCN corrected biological parameters (lactate:
2.6±1.00 mmol/L, pH: 7.41±0.03, HCO3-: 27.66±1.24 mmol/L).
Our study demonstrates the putative beneficial effect of O-GlcNAc stimu-
lation during sepsis, especially by NbutGT. It remains to be determined
whether the improved biological parameters are associated with a reduced
mortality of rats.
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Hyperglycemia is a feature of septic patient and has been associated with
poor outcome and higher mortality. In contrast insulin has been shown to
decrease mortality and to prevent the incidence of multi-organ failure but is
often associated with deleterious hypoglycemia. Protein Tyrosine Phosphatase
1B (PTP1B) is a negative regulator of insulin signaling and NO production.
Recently we showed that PTP1B gene deletion improves cardiovascular dys-
function during endotoxemia. However, the effect of PTP1B inhibition on glu-
cose metabolism and cardiovascular insulin resistance during sepsis is
unknown.
Thus, in order to address this question, we developed a Cecal Ligation and
Puncture (CLP) model of sepsis which is known to reproduce metabolic dis-
orders of clinical sepsis. Impaired glucose metabolism was found in mice 16
hours after CLP induction as shown by the disruption of glucose intake and
insulin response during glucose (GTT) and insulin (ITT) tolerance tests.
PTP1B–/– mice showed improved GTT and ITT (GTT 120min: CLP WT
20.1±2.1, CLP PTP1B–/– 12.5±2.4 mmol/L, p<0.001; ITT 120min: CLP WT
2.4±0.2, CLP PTP1B–/– 0.60±0.03 mmol/L, p<0.001) demonstrating an
improvement of glucose metabolism. Insulin- and flow-mediated dilatation
assessed in isolated-perfused mesenteric arteries was abolished by CLP and
was improved by ex vivo PTP1B inhibition (% dilatation: Ins10-5M, CLP
7±2, CLP+PTP1Bi 18±4%, p<0.01; 200 μl/min flow, CLP 1±1, CLP +
PTP1Bi 13±3%, p<0.01). Arteries isolated from PTP1B-/- mice were pro-
tected against TNF-α induced impairment of dilation to insulin. We found that
PTP1B-/- mice subjected to CLP had a higher survival rate compared to WT.
Thus, PTP1B gene deletion or inhibition limits sepsis-induced hypergly-
cemia and insulin resistance associated with reduced vascular dysfunction and
increased survival. PTP1B inhibition may represent a new strategy in the treat-
ment of septic insulin resistance with hyperglycemia.
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Introduction: Septic shock-induced disseminated intravascular coagulop-
athy (DIC) contributes to endothelial dysfunction, multiple organ failure and
high mortality rate. Our aim was to assess the interest of procoagulant micro-
particles (MPs) as surrogates of vascular cell and as possible biomarkers in
DIC.
Patients and methods: Prospective multicenter study of 100 consecutive
adult patients with septic shock enrolled at admission in medical intensive
care units. Hemostasis parameters were analyzed, MPs measured by prothrom-
binase assay after capture onto insolubilized annexin-5 or biotinylated anti-
bodies.
Results: Among analyzed 92 cases, 40 had DIC during the first 24 hours.
Routine clotting and hemostasis assays failed to identify vascular cell involve-
ment. Compared to normal range, patients with septic shock had a three-fold
increase (p<0.001) in total MPs at D1, remaining elevated at D7, regardless of
DIC diagnosis. Regardless of the presence of DIC (p=0.15), endothelial cell
apoptosis was suggested by a major increase in CD31-MPs that remained ele-
vated until D7 (p=0.19). Endothelial activation was assessed by CD105-MPs,
which remained dramatically increased in DIC (DIC at D1: 2.7•2.4 nM and
DIC at D2: 1.8•1.7 nM, vs. no DIC: 0.8•0.6 nM, p<0.001) and tended to return
to baseline at the end of the follow-up period (p<0.05). No alteration in E-
selectin (CD62E-MPs) levels could be detected. CD105-MPs (OR 6.55) and
CD31-MPs (OR 0.49) were associated with early DIC in multivariate analysis
and can originally predict it. Furthermore, leukocyte CD11a-MPs were also
higher in DIC highlighting that endothelial cells and leukocytes are first
implied in the process of DIC.
Conclusion: Endothelial-derived MPs are relevant biomarkers of early
vascular injury and endothelial dysfunction in septic shock-induced DIC and
could prove useful for patients’ stratification.
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Introduction: Circulating procoagulant microparticles (MPs) take part in
septic shock vascular dysfunction through pro-inflammatory and procoagulant
detrimental effects. Aims were to study how circulating procoagulant MPs are
involved in the vascular dysfunction of septic shock and to examine if the
pharmacological modulation of MP could be beneficial.
Methods: In a first set of experiments, MPs were isolated from sham or
septic rats obtained by cecal ligation and puncture, resuscitated and treated by
activated protein C (aPC). Then, healthy recipients were inoculated with septic
MPs and hemodynamic parameters were recorded during 4 hours. At the end
of the record, blood and organs were harvested.
Results: Treating septic rats with aPC significantly reduced norepinephrine
needs to reach the mean arterial pressure goal and leukocyte-derived MPs
(6.2±2.1 vs 2.9±1.7 nM PhtdSer, p<0.05, n=16). MPs from septic rats signif-
icantly decreased the mean arterial pressure of healthy recipients (83±9 vs
107±2 mmHg), a deleterious hemodynamic effect also prevented by aPC treat-
ment (120±6 mmHg), possibly through the elevation of MP thromboxane con-
tent (77.1±11.4 pg/ml vs 39.8±4.5 pg/ml in sham-NaCl MPs, p<0.05, n=12).
A decreased arterial inflammation in mesenteric resistance arteries and heart
was also evidenced by western blotting (40-50% reduction in NF-KB and
pIκB-α staining). Of note, inoculation of MPs from aPC-treated septic rats
altered MP phenotype. Recipients had elevated circulating levels of platelet
and endothelial MPs.
Conclusions: During sepsis, MPs modulate the inflammatory response in
cardiac and vascular tissues and contribute to septic hemodynamic dysfunc-
